MilliporeSigma: Navigating Growth from Pre-GLP to GMP

November 28, 2017

Share :

Time: 3:00PM - 7:00PM
Location: Lobby

Join MilliporeSigma as they chair a panel discussion focused on planning for GMP from pre-GLP place. When it comes to drug development, it is critical to anticipate and overcome challenges rapidly when transitioning from pre-clinical POC studies into clinical studies. The earlier companies consider risks and long-term effects of raw materials, technologies and process performance, the higher their chances to succeed in development will be. 


2:30PM | Registration/Check-in
3:00PM | Welcome and Introductions
3:15PM | Presentation: Start with the End in Mind - Tom Beil, Head of Quality Services, MilliporeSigma
4:00PM | Panel Discussion​

  • Jim Neville, Director of Technology Management, MilliporeSigma Life Science Process Solutions
  • Janmeet Anant, MilliporeSigma Life Science Quality and Regulatory Expert
  • Beth Goodrich, Head of Applications Engineering, MilliporeSigma Life Science Process Solutions
  • Nick Keener, Director Process Development, Amgen
  • Pat Biamou, Head of BioDevelopment Americas, BioReliance End to End Solutions
  • David T. Beattie, Ph.D., MBA  Senior Director of R&D, MilliporeSigma Life Science Process Solutions

5:00PM | Golden Ticket Presentation - Mike Trassati, Head of Americas, PharmaProcessing Commercial
5:15PM | Networking Reception